P2-1-23Final survival analysis of the phase II Study of weekly paclitaxel plus bevacizumab in previously treated non-Sq NSCLC
2015
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI